339 related articles for article (PubMed ID: 814800)
21. The role of central serotonergic mechanisms on head-twitch and backward locomotion induced by hallucinogenic drugs.
Yamamoto T; Ueki S
Pharmacol Biochem Behav; 1981 Jan; 14(1):89-95. PubMed ID: 6258178
[TBL] [Abstract][Full Text] [Related]
22. Hallucinogens potentiate responses to serotonin and norepinephrine in the facial motor nucleus.
McCall RB; Aghajanian GK
Life Sci; 1980 Apr; 26(14):1149-56. PubMed ID: 7392793
[No Abstract] [Full Text] [Related]
23. Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.
Titeler M; Lyon RA; Glennon RA
Psychopharmacology (Berl); 1988; 94(2):213-6. PubMed ID: 3127847
[TBL] [Abstract][Full Text] [Related]
24. The influence of hallucinogenic drugs upon in vivo brain levels of adenine nucleotides, phosphocreatine and inorganic phosphate in the rat.
Lewis JJ; Ritchie AP; van Petten GR
Br J Pharmacol Chemother; 1965 Dec; 25(3):631-7. PubMed ID: 5296835
[No Abstract] [Full Text] [Related]
25. A comparison of psychotomimetic drug effects on rat brain norepinephrine metabolism.
Stolk JM; Barchas JD; Goldstein M; Boggan W; Freedman DX
J Pharmacol Exp Ther; 1974 Apr; 189(1):42-50. PubMed ID: 4823298
[No Abstract] [Full Text] [Related]
26. 'Hallucinogenic drugs and central transmitter substances'.
Leonard BE
Int J Neurosci; 1972 Jul; 4(1):35-43. PubMed ID: 4348844
[No Abstract] [Full Text] [Related]
27. Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat.
Schoenfeld RI
Science; 1976 May; 192(4241):801-3. PubMed ID: 1063447
[TBL] [Abstract][Full Text] [Related]
28. Effects of DOM and DMT in a proposed animal model of hallucinogenic activity.
Adams LM; Geyer MA
Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(2):121-32. PubMed ID: 3858911
[TBL] [Abstract][Full Text] [Related]
29. Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys.
Fantegrossi WE; Woods JH; Winger G
Behav Pharmacol; 2004 Mar; 15(2):149-57. PubMed ID: 15096915
[TBL] [Abstract][Full Text] [Related]
30. PATTERNS OF HALLUCINOGENIC DRUG ABUSE.
LUDWIG AM; LEVINE J
JAMA; 1965 Jan; 191():92-6. PubMed ID: 14233246
[No Abstract] [Full Text] [Related]
31. Contractile responses of guinea pig umbilical arteries to various hallucinogenic agents.
Nair X
Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):535-42. PubMed ID: 4445570
[No Abstract] [Full Text] [Related]
32. Discriminable stimuli produced by hallucinogens.
Kuhn DM; White FJ; Appel JB
Psychopharmacol Commun; 1976; 2(4):345-8. PubMed ID: 996285
[No Abstract] [Full Text] [Related]
33. Management of hallucinogen abuse.
Haddad LM
Am Fam Physician; 1976 Jul; 14(1):82-7. PubMed ID: 1065215
[TBL] [Abstract][Full Text] [Related]
34. Naloxone alters the effects of LSD, DOM and quipazine on operant behavior of rats.
Mokler DJ; Commissaris RL; Henck JW; Rech RH
Pharmacol Biochem Behav; 1984 Sep; 21(3):333-7. PubMed ID: 6593750
[TBL] [Abstract][Full Text] [Related]
35. d-LSD binding to brain homogenates: possible relationship to serotonin receptors.
Bennett JL; Aghajanian GK
Life Sci; 1974 Dec; 15(11):1935-44. PubMed ID: 4620998
[No Abstract] [Full Text] [Related]
36. EEG effects of hallucinogens and cannabinoids using sleep-waking behavior as baseline.
Fairchild MD; Jenden DJ; Mickey MR; Yale C
Pharmacol Biochem Behav; 1980 Jan; 12(1):99-105. PubMed ID: 6102770
[TBL] [Abstract][Full Text] [Related]
37. The mechanism of action of hallucinogenic drugs on a possible serotonin receptor in the brain.
Smythies JR; Benington F; Morin RD
Int Rev Neurobiol; 1970; 12():207-33. PubMed ID: 4918144
[No Abstract] [Full Text] [Related]
38. Inhibition of isolation-induced attack behavior of mice by drugs.
Uyeno ET
J Pharm Sci; 1966 Feb; 55(2):215-6. PubMed ID: 5923276
[No Abstract] [Full Text] [Related]
39. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
Callahan PM; Appel JB
J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
[TBL] [Abstract][Full Text] [Related]
40. Cross tolerance or tachyphylaxis among various psychotomimetic agents on cats.
Wallach MB; Hine B; Gershon S
Eur J Pharmacol; 1974 Nov; 29(1):89-92. PubMed ID: 4435048
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
